Srinivasa Reddy is the Chief Science Officer at Cube Psytech Corp, a Canadian company focusing on pioneering in solving the mental health issues through psychedelics. Srinivasa Reddy served as various roles nationally and internationally in the past. His eight (8) years of Cannabis and other commercially important crop industry experience includes optimization of controlled environmental facilities, extraction protocols, research and development of micro, macro and nano cannabinoids, terpenoids and flavonoids to conjugate with several other naturally occurring health beneficial compounds.
His wide experience and interdisciplinary education background in Biotechnology, Cancer biology, Biochemistry, Genetics, controlled environmental agriculture, Plant based medicine. Srinivasa Reddy worked as COO of Leaf Cross Biomedicals (LP-Processing and Sales) and CEO of PhytoteQ Innovations in the past.
Cube Psytech is currently submitted for the application for psychedelic activities aiming to focus on the new range of psilocybin derived molecules used in various mental health treatments. Cube Psytech also working on innovations in natural compounds as alternative supplements, plant-based medications through precision drug delivery system and nano technology. Company developing relation with global leaders in the drug development, intellectual property in innovative high efficacy plant and mycelium-based molecules.
Srinivasa Reddy is also board member of several international organizations. He is an internationally recognized speaker in the global cannabis industry.
